COCIR concerns in the event of a no-deal Brexit

Open letter

COCIR concerns in the event of a no-deal Brexit

COCIR, the European Coordination Committee of the Radiological, Electromedical and Healthcare IT Industry, published an open letter to the European Commission & National Competent Authorities for Medical Devices.

The date of withdrawal of the United Kingdom from the European Union - 29 March 2019 - is drawing ever-closer. While we sincerely hope that both parties will continue to do their utmost to find an agreement, our industry is increasingly concerned over preparations for a “no-deal scenario”. Such an outcome means that the UK will no longer remain part of the European Single Market. Given recent communications by the European Commission (1), this will have detrimental consequences for our industries in the European Union.

Our major concerns are that:

  • UK Notified Bodies, which currently play a critical role in certifying medical devices placed on the EU-27 market, will no longer be able to issue EU certificates.
  • Non-EU manufacturers that currently have an Authorised Representative based in the UK will have to change to one based in the EU-27.
  • Manufacturers transferring to a new – EU-27-based - Notified Body will need to change how their devices are labelled to reflect the new Notified Body number or face non-compliance with the Medical Device Directives.

Unfortunately, it appears that the European Commission and the EU-27 Member States are currently not planning to adopt a specific transition period for medical devices (similar to the one planned by the UK). However, we would like to point out that the current timing is insufficient to allow for manufacturers to receive certification by a new Notified Body. Even where a transfer is possible, and new CE certificates from EU-27 based Notified Bodies have only been issued in the last few weeks, re-labelling all their devices would be challenging at best and unfeasible in many cases, particularly for manufacturers with large product portfolios. If devices are not available, even temporarily, the resulting impact on European healthcare systems – and the safety of EU citizens - could be substantial.

Therefore, in the best interest of citizens, we call on the European Commission, together with Member States, to agree on a limited transition period. This will allow those manufacturers directly impacted by any no-deal Brexit to continue to place devices certified by a UK Notified Body on the market.

Standard practice for medical devices (2) when changing to a different Notified Body would be to provide six months following the Date of Withdrawal. This would allow the re-labelling of devices after the certificates transition to a new Notified Body. Even 12 to 18 months could be necessary in case manufacturers have to switch to a completely new Notified Body to ensure the necessary time for the re-certification process.

Such a transition would give manufacturers much-needed certainty and ensure that hospitals, healthcare professionals and citizens in the EU see reliable and predictable access to these devices. This, however, provides a short-term solution to a long-term challenge. We therefore encourage the EU and the UK to expedite negotiations on a trade agreement that includes the mutual recognition of medical device certification.

1 - ec.europa.eu/info/sites/info/files/qa_brexit_industrial_products_en.pdf
2 - www.doks.nbog.eu/Doks/NBOG_BPG_2006_1.pdf

Source: COCIR

08.03.2019

Read all latest stories

Related articles

Photo

Regulation

Implementing MDR is complex and expensive and holds little reality

By 2020 medical devices manufacturers must document the clinical effectiveness of their devices more extensively. The Medical Device Regulation (MDR) presents a fundamental impact on innovation and…

Photo

New device

Launching: the portable medical imaging workstation

German firm Plum Medical Solutions is launching its 2nd generation MED-TAB, reported to be the world’s first portable medical imaging workstation. ‘It’s the only standards compliant portable…

Medical device regulation in the EU and US needs urgent reform

Patients and clinicians need greater regulatory transparency to make informed decisions about treatment Medical devices approved first in the European Union (EU) are associated with a greater rate of…

Related products

Shimadzu – Flexavision series

Fluoroscopy

Shimadzu – Flexavision series

Shimadzu Europa GmbH